Generation Bio Co (GBIO) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $5.34
• Market Cap: $35.98M
• EPS: $-9.37
• 52-Week High: $6.95
• 52-Week Low: $3.00

Market Sentiment

Generation Bio Co currently has a Bearish sentiment score of -0.42.

About Generation Bio Co

Generation Bio Co. is an innovative genetic drug company based in Cambridge, Massachusetts, dedicated to advancing groundbreaking gene therapies aimed at both rare and prevalent diseases. Utilizing its proprietary gene delivery platform, the company is committed to addressing critical unmet medical needs through the development of transformative treatments that promise enduring benefits. With a robust focus on research and development, Generation Bio is strategically positioned to emerge as a...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Generation Bio Co and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does GBIO pay dividends?

Generation Bio Co (GBIO) does not currently pay a regular dividend.

What is GBIO's market cap?

Generation Bio Co (GBIO) has a market capitalization of $35.98M with a current stock price of $5.34.